Ahmet Günkan, MD (@doctorgunkan) header
Ahmet Günkan, MD (@doctorgunkan) profile picture

🧠 Radiologist @ESOstroke Social Media and PR committee UoA Tucson, VIR

Joined December 2020
Photo by Ahmet Günkan, MD (@doctorgunkan)Photo by Ahmet Günkan, MD (@doctorgunkan)Photo by Ahmet Günkan, MD (@doctorgunkan)Photo by Ahmet Günkan, MD (@doctorgunkan)Photo by Ahmet Günkan, MD (@doctorgunkan)Photo by Ahmet Günkan, MD (@doctorgunkan)Photo by Ahmet Günkan, MD (@doctorgunkan)Photo by Ahmet Günkan, MD (@doctorgunkan)Photo by Ahmet Günkan, MD (@doctorgunkan)
Our meta-analysis of RCTs showed a significant benefit of thrombolysis beyond 4.5h (without MT) for ischemic stroke patients. @StrokeAHA_ASA ahajournals.org/doi/10.1161/… @FerreiraMY_MD @JhonBocanegraB1 @MVilardo @adnan_mujanovic @PascalJabbourMD @yafellserulle @NguyenThanhMD
2
14
2
52
5,984
We strike again! Our latest study just published in Neurosurgery @CNS_Update 4,500+ patients: longer stent retrievers → better first-pass reperfusion, same complication rate. Take-home: length matters — but let anatomy and clot guide the choice. #neurosurgery #stroke #LVO
2
5
6
1,016
Ahmet Günkan, MD retweeted
🧠 Mechanical thrombectomy (MT) is a well-established treatment for eligible patients with large-vessel occlusion acute ischemic stroke. However, its safety and efficacy in elderly patients remain a matter of debate. In our recently published study in The Neuroradiology Journal, we analyzed data from 15 randomized clinical trials including elderly patients (≥70 years) treated with MT versus standard medical management. We also explored potential effect modifiers such as stroke severity, anterior versus posterior circulation, use of general anesthesia, time from onset to randomization, country socioeconomic status, infarct size, and imaging selection strategies. 💡Key findings: ↪ MT was associated with higher rates of functional independence and functional recovery at 90 days. ↪ Lower rates of severe disability were observed in the thrombectomy group. ↪ Mortality was reduced, particularly among patients over 80 years. ↪ Benefits were consistent across circulation territories and most subgroup analyses, including large infarcts. We discuss how these findings integrate with the current literature and contemporary guideline recommendations, while also addressing remaining gaps and future research directions for this growing and clinically complex population. I would like to sincerely thank all my coauthors, @doctorgunkan and @FerreiraMY_MD for their guidance, Professors Panagiotis Papanagiotou and Jean-Claude Baron for their supervision and insights, and Sávio Batista for the original study idea. Full text link: doi.org/10.1177/197140092614… #stroke #neurology #endovascular #thrombectomy #neurosurgery @christiankfuku @OcilioRoch60949 @Andersonmhps
1
1
9
318
Ahmet Günkan, MD retweeted
"Efficacy and Safety of Flow Diversion for Distal Anterior Cerebral Aneurysms: A Systematic Review and Proportional Meta-Analysis" doi.org/10.3174/ajnr.A8926 @MVilardo @doctorgunkan @ElekAlperen @jpscarramal @LeonardoC_MD @theAJNR_EIC @dronalylmz
1
7
13
1,494
Ahmet Günkan, MD retweeted
Sharing our latest publication! Grateful for the collaboration and the chance to contribute to this field. @ahsheadache @HeadacheJournal @amfmigraine @MigraineDisordr @CLENeurons #Neurology #MedEd #Headache
🎧 A recent review finds #vestibular rehabilitation may meaningfully improve #dizziness in people with vestibular #migraine. More consistent research is still needed, but early results are promising. #VestibularMigraine 🔗headachejournal.onlinelibrar… @MVilardo @bradleyongmd et al
1
4
1
10
1,908
Ahmet Günkan, MD retweeted
Headache after stroke is still overlooked, and it deserves a lot more attention than it gets! @ahsheadache @WorldHeadache @HeadacheJournal @headache @CLENeurons
🧠 Nearly half of people may experience #headaches after a hemorrhagic #stroke, many lasting months or years. A recent review highlights the need for better recognition & care. 🔗headachejournal.onlinelibrar… @bradleyongmd @shervinbd @MVilardo et al
2
4
9
1,259
Ahmet Günkan, MD retweeted
Einstein & the Brain: Relativity of Time in Ischemic Stroke Treatment #BloggingStroke contributor Ingrid Marques discusses #Stroke article by @doctorgunkan et al. @PascalJabbourMD @NguyenThanhMD @adnan_mujanovic @JhonBocanegraB1 @MVilardo @Dr_LeonardoC ahajournals.org/do/10.1161/b…
1
23
1
83
6,058
I am sharing another publication in the European Stroke Journal: Association between the no-reflow phenomenon and clinical outcomes after endovascular treatment for acute ischemic stroke: A systematic review and meta-analysis academic.oup.com/esj/article… @ESOstroke @OcilioRoch60949 #Stroke #EndovascularTherapy #NoReflow #MetaAnalysis
4
5
734
Our new study is out in Endocrine We reviewed how machine learning models can predict post-op remission in pituitary adenoma. Huge thanks to @Ricardokomotar ,@DoctorAaronson ,@doctorgunkan ,@Bardii47 , @AliMortezaei97 and @VratkoH 📎 doi.org/10.1007/s12020-025-0…
3
16
1,325
New publication in @NRADjournal! Updated meta-analysis on the safety and efficacy of the Woven EndoBridge (WEB) device for ruptured intracranial aneurysms. Check it out! #Neuroradiology #Aneurysm #WovenEndoBridge #MedicalResearch #Neurosurgery doi.org/10.1007/s00234-025-0…
1
3
270
Flow diversion for distal cerebral aneurysms – our meta-analysis of 445 DCAs shows high occlusion & low complication rates. Grateful to contribute! 🔗 doi.org/10.1136/jnis-2025-02… @AdamDmytriw @VitorMendesPer1 @dronalylmz @JNIS_BMJ @MVilardo @jpscarramal @JhonBocanegraB1
2
3
9
784
I am deeply saddened by the news of Prof. Gazi Yaşargil’s passing, and so close to his 100th birthday and the @yasargil100 Symposium to honor him. I am presenting in Zürich in a few weeks and was greatly looking forward to meeting Dr. Yaşargil, and giving him this portrait. Truly one of the most remarkable neurosurgeons of all time. #Yasargil #RestInPeace
15
231
20
1,844
76,650
Dear @FedEx, many of us rely on accurate delivery estimates. There’s been a known strike in Campinas, Brazil since Nov 2024, delaying shipments by weeks. Yet your system still promises 2-day delivery. Please inform customers honestly.
1
287
Ahmet Günkan, MD retweeted
Presented at #ESOC2025: Tirofiban, an IV antiplatelet, given as an adjunct to IVT, improved the odds of excellent functional outcome in patients with AIS, at the cost of an increased risk of intracranial bleeding in the ASSET-IT trial #VoiceOfStroke
17
57
3,748
Ahmet Günkan, MD retweeted
ICYMI: Check out the March 2025 episode of the #StrokeAlert Podcast. In this episode, host @NAsdaghi addresses these three questions. ahajournals.org/do/10.1161/p… @EricGoldsteinMD @NKrementzMD @mayank_G0 @mihill68 #stroke #StayAlertWithStrokeAlert #AHAJournals
1
6
8
2,163
Ahmet Günkan, MD retweeted
🧵In a meta-analysis of randomized controlled trials that enrolled patients with acute ischemic stroke beyond 4.5 hours of time last known well, administration of thrombolysis (compared with placebo) led to a higher odds of a good functional outcome despite a higher odds of sICH.
2
48
98
8,072
Ahmet Günkan, MD retweeted
The March episode of the #StrokeAlert Podcast is now available. In this episode, host @NAsdaghi highlights articles in the March issue of #Stroke and interviews @mayank_G0 & @mihill68 about the ESCAPE-MeVO trial. #AHAJournals #StayAlertWithStrokeAlert ahajournals.org/do/10.1161/p…
1
7
16
2,286
1
2
8
642